Alzheimer's disease (AD) is a common, debilitating neurodegenerative disease affecting about 10 percent of people over the age of 65 and one third of people aged 85 and above. Besides environmental ...

The molecular pathogenesis of Alzheimer’s disease (AD) is complex and sparsely understood. The relationship between AD’s amyloid β (Aβ) peptides and neuronal membranes is central to Aβ’s cytotoxicity ...

Alzheimer's disease (AD) is a common, debilitating neurodegenerative disease affecting about 10% of people over the age of 65 ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

INmune Bio's ATM offering raises $19M ahead of Phase II results, but disappointing data and dilution signal risks. Read here ...

The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest with recent years witnessing several important controversies.

New research reveals that Alzheimer's disease may impair nerve function not by reducing myelin, but by altering the proteins ...

Although scientists have made significant progress in understanding the disease, there’s still no cure. That’s partly because ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...